HIGHLIGHTS
- who: Lucas W. Rowe from the Department of Ophthalmology, Indiana University School of Medicine have published the paper: Intravitreal sirolimus with adjunct aflibercept versus aflibercept monotherapy for persistent, exudative age-related macular degeneration: a pilot study, in the Journal: (JOURNAL) of 11/03/2016
- what: Methods This institutional review board approved registered (NCT02732899) prospective subject-masked single center randomized controlled trial in subjects with persistent exudative age-related macular degeneration compared alternating monthly intravitreal sirolimus and aflibercept (combination) versus aflibercept monotherapy (control) every 2 months over the course of 36 weeks. The study showed a . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.